{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2011"],"condition":["Major Advanced Solid Tumors Other Than Colorectal"],"disease":["Major Advanced Solid Tumors Other Than Colorectal"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2110616"],"location":["United States"],"study_start_month":["11"],"keyword":["Pharma Mar","Non-Colorectal Cancer (non-CRC)","PM01183","Dose finding phase I"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks","description":"Phase I Study of PM01183 in Non-Colorectal Cancer Patients to determine the recommended dose (RD) of PM01183.","dates":{"creation":"2011-11-15"},"accession":"2110616","cross_references":{"ClinicalTrials___gov":["NCT01405391"]}}